The British Journal of Psychiatry (2006) 189: 527-532. doi: 10.1192/bjp.bp.106.021386
© 2006 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by BARROWCLOUGH, C.
Right arrow Articles by GREGG, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BARROWCLOUGH, C.
Right arrow Articles by GREGG, L.

Group cognitive–behavioural therapy for schizophrenia

Randomised controlled trial

CHRISTINE BARROWCLOUGH, PhD, GILLIAN HADDOCK, PhD, FIONA LOBBAN, PhD and STEVE JONES, PhD

School of Psychological Sciences, University of Manchester, UK

RON SIDDLE, PhD

Manchester Mental Health & Social Care Trust, Manchester, UK

CHRIS ROBERTS

School of Epidemiology and Health Science, University of Manchester, UK

LYNSEY GREGG, MSc

School of Psychological Sciences, University of Manchester, UK

Correspondence: Professor Christine Barrowclough, School of Psychological Sciences, Rutherford House, Manchester Science Park, Lloyd Street North, Manchester M15 6SZ, UK. Email: christine.barrowclough{at}manchester.ac.uk

Declaration of interest None. Funding detailed in Acknowledgements.

Background The efficacy of cognitive–behavioural therapy for schizophrenia is established, butthere is less evidence for a group format.

Aims To evaluate the effectiveness of group cognitive–behavioural therapy for schizophrenia.

Method In all, 113 people with persistent positive symptoms of schizophrenia were assigned to receive group cognitive–behavioural therapy or treatment as usual. The primary outcome was positive symptom improvement on the Positive and Negative Syndrome Scales. Secondary outcome measures included symptoms, functioning, relapses, hopelessness and self-esteem.

Results There were no significant differences between the cognitive–behavioural therapy and treatment as usual on measures of symptoms or functioning or relapse, but group cognitive–behavioural therapy treatment resulted in reductions in feelings of hopelessness and in low self-esteem.

Conclusions Although group cognitive–behavioural therapy may not be the optimum treatment method for reducing hallucinations and delusions, it may have important benefits, including feeling less negative about oneself and less hopeless for the future.




This article has been cited by other articles:


Home page
 Behav ModifHome page
B. C. Frueh, A. L. Grubaugh, K. J. Cusack, and J. D. Elhai
Disseminating Evidence-Based Practices for Adults With PTSD and Severe Mental Illness in Public-Sector Mental Health Agencies
Behav Modif, January 1, 2009; 33(1): 66 - 81.
[Abstract] [PDF]

Home page
 Evid. Based Ment. HealthHome page
Et al
Evid. Based Ment. Health, August 1, 2007; 10(3): 71 - 72.
[Full Text] [PDF]